Grand Island, USA

Fresenius Kabi USA develops, manufactures and markets injectable pharmaceuticals, with important products in the oncology, anti-infective, anaesthetic / analgesic and critical care fields. Fresenius Kabi USA operates out of two sites, located in upstate New York and Illinois.

The Grand Island facility is located just a few minutes from the spectacular Niagara Falls, near Buffalo. The site employs approximately 600 people in three buildings. The main building houses aseptic wash and fill (terminal sterilization) manufacturing processes. In the other buildings are offices, laboratories, the warehouse, and a new manufacturing area, with some space for expansion.

Technologies:

• Lyophilization
• Aseptic liquid filling
• Aseptic SCF syringes
• Terminal sterilization

Products:

• Oncologics
• Anti-infectives
• Anaesthetics
• Analgesics
• Critical care

Containers:

• Pre-filled Syringes (1 - 5 ml)
• Plastic vials (3 - 50 ml)
• Glass vials (2 - 200 ml)

Certificates:

• US-FDA

Markets:

• USA